We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more


Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 4035600
Fax: +353 1 4035687
Medical Information e-mail: iemedinfo@sanofi.com

Summary of Product Characteristics last updated on medicines.ie: 22/12/2016
SPC Dioralyte Natural

Go to top of the page

Dioralyte Natural Powder for Oral Solution

Go to top of the page

Each sachet contains:

Sodium Chloride 0.47g

Potassium Chloride 0.30g

Glucose 3.56g

Disodium Hydrogen Citrate 0.53g

For a full list of excipients, see section 6.1.

Go to top of the page

Powder for oral solution.

White, homogenous, granular powder.

Go to top of the page

Go to top of the page
4.1 Therapeutic indications

In the oral correction of fluid and electrolyte loss and in the management of watery diarrhoea.

Go to top of the page
4.2 Posology and method of administration

The basic unit of dosage is the content of a single sachet reconstituted in 200ml (approximately 7 fluid ounces) of drinking water. Use fresh drinking water for adults and children. For infants where drinking water is unavailable the water should be freshly boiled and cooled. The solution should be made up immediately before use. If refrigerated, the solution may be stored for up to 24 hours, otherwise any solution remaining an hour after reconstitution should be discarded.

The solution must not be boiled after reconstitution.

Daily intake may be based on a volume of 150ml/kg body weight for infants and 20-40 mg/kg body weight for adults and children. A reasonable approximation is:

Infants - One to one and a half times the usual feed volume. For infants under 12 months, use only under medical advice

Children - One sachet after every loose motion.

Adults including elderly- One or two sachets after every loose motion.

More may be required initially to ensure early and full volume repletion.

Go to top of the page
4.3 Contraindications

There are no known contra-indications to Dioralyte.

Go to top of the page
4.4 Special warnings and precautions for use

The solution must not be reconstituted except with water at the volume stated.

Solutions of greater concentration may result in hypernatraemia. Those of greater dilution may result in inadequate replacement.

If there is no improvement within 24-48 hours the physician should be consulted.

For infants under 12 months use only on medical advice.

If nausea and vomiting are present with the diarrhoea, small but frequent amounts of dioralyte should be drunk at first.

For use in the elderly no specific precautions are necessary. However, care should be taken when administering glucose-electrolyte solutions in cases of severe renal or hepatic impairment or other conditions where the normal electrolyte balance may be distributed.

Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction


4.6 Pregnancy and lactation

Dioralyte Natural is not contra-indicated in pregnancy or lactation.

Go to top of the page
4.7 Effects on ability to drive and use machines


Go to top of the page
4.8 Undesirable effects

None stated.

Reporting of suspected adverse reactions

Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

Go to top of the page
4.9 Overdose

In the event of significant overdose, serum electrolytes should be evaluated as soon as possible, appropriate steps taken to correct any abnormalities and levels monitored until return to normal levels is established. This is particularly important in the very young and in cases of severe hepatic or renal failure.

Go to top of the page

Go to top of the page
5.1 Pharmacodynamic properties

Dioralyte is an oral rehydration therapy. The combination of electrolytes stimulates water and electrolyte absorption from the gastro-intestinal tract and therefore prevents dehydration in diarrhoea.

Go to top of the page
5.2 Pharmacokinetic properties

Sodium and glucose are actively transported via the membrane into the enterocytes. Sodium is then extruded into the intercellular spaces and the resulting osmotic gradient causes water and electrolytes to be drawn from the gut and then into the circulation.

Go to top of the page
5.3 Preclinical safety data


Go to top of the page

Go to top of the page
6.1 List of excipient(s)

Colloidal Anhydrous Silica

Saccharin Sodium

Go to top of the page
6.2 Incompatibilities

Not applicable.

Go to top of the page
6.3 Shelf life

3 years.

Go to top of the page
6.4 Special precautions for storage

Store below 25°C. Store in the original package in order to protect from moisture. The reconstituted solution should be used immediately but may be stored for up to 24 hours in a refrigerator at 2-8°C.

Go to top of the page
6.5 Nature and contents of container

Foil /polyethylene laminate sachets containing powder for reconstitution, packed in outer cartons.

Pack sizes: 3, 6, 7, 10, 14, 20, 30 Sachets.

Not all pack sizes are marketed.

Go to top of the page
6.6 Special precautions for disposal and other handling

The solution should be prepared immediately before use.

The contents of each sachet should be dissolved in 200ml (approximately 7 fluid ounces) of drinking/cooled boiled water where relevant.

Do not boil the solution after reconstitution.

Go to top of the page

sanofi-aventis Ireland Ltd. T/A SANOFI,

Citywest Business Campus,

Dublin 24.

Go to top of the page

PA 540/99/1

Go to top of the page

13th July 1989/3rd June 2007.

Go to top of the page

December 2016.

Link to this document from your website:

Document Links

  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share